Novartis has claimed accelerated approval from the FDA for a second indication for Fabhalta – IgA nephropathy (IgAN) – as it charts a course to blockbuster sales for the drug. The US regulator has ...

GSK's business development team have been working overtime of late, with three R&D deals announced in the last few days across Alzheimer's disease and cancer. The Alzheimer's agreement – with ...

Our office serves first-generation students, students from income-eligible backgrounds and students with a documented disability as they work toward earning their college degree. If you are one such ...

PS Plus is looking to have a strong end of the year with some big titles on the service after what has been a mixed year. Some months have been fantastic, but there have also been some real duds. The ...

HAMMOND — A trio of private schools has joined together to acquire the former Spohn School building from City Baptist Schools, and is set to open a new K-5th grade school next year, the City of ...